Stock Evaluator: Alpha Tau Medical Ltd. (DRTS)

Alpha Tau Medical Ltd. DRTS

$11.79 -0.10 -0.84%
July 31, 2026 4:00:00 PM EST November 10, 2021 Volume: 264,213
After Hours: $120.37   0.15  |  0.12% November 10, 2021 7:59 PM EST Volume: 72,713
USD NASD | DELAYED PRICE
SECTOR INDUSTRY
Health Care Health Care Equipment & Supplies

A+ Stock Grade Summary:

VALUE:
GROWTH:
MOMENTUM:
EPS REVISIONS:
QUALITY:
COMPANY SUMMARY
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical clinical studies for mouse tumors and human-derived tumors. The company has a strategic collaboration agreement to develop and commercialize Alpha DaRT for the treatment of prostate cancer. The company is headquartered in Jerusalem, Israel.

Commentary & Analysis


Financial Summary

Share Statistics DRTS Industry
Median
Percentile
(All Stocks)
Market Cap (Mil) $1,073.1 $334.8 46%
Shares Out (Mil) 86.2 41.7 59%
Institutional Ownership 24.0% 77.3% 11%
Float (Mil) 62.1 34.7 52%
Beta 1.12 0.86 66%
Avg Daily Volume (000s) 676 266 64%
Price Change
(52-week)
309.7% 60.7% 99%
Growth DRTS Industry
Median
Percentile
(All Stocks)
Sales (5yr) na 11.8% na
Net Income (5yr) (36.8%) (5.8%) 10%
EPS (5yr) (19.1%) 10.7% 14
Dividends (5yr) na 0.0% na
Cash Flow (5yr) (15.5%) (16.1%) 48%
Estimates Qtrly Current
Fiscal
Year
Next
Fiscal
Year
# of Estimates 4 5 5
Current EPS ($0.141) ($0.659) ($0.515)
Month Ago EPS ($0.141) ($0.659) ($0.515)
# Rev Up 0 0 0
# Rev Down 1 2 3
Three Months Ago EPS ($0.124) ($0.511) ($0.426)
Year/Year Chg 0.0% 24.6% (43.3%)
Financials DRTS Industry
Median
Percentile
(All Stocks)
Sales (TTM) (Mil) na $152 na
Net Income (TTM) (Mil) ($43) ($11) 17%
EPS (TTM) ($0.529) ($0.500) 27%
Operating Cash Flow (TTM) (Mil) ($27) ($2) 13%
Net Cash Flow (TTM) (Mil) na $1 na
Long-Term Debt (Q1) (Mil) $13 $22 30%
Enterprise Value (Q1) (Mil) $363 $304 31%
Valuation DRTS Industry
Median
Percentile
(All Stocks)
P/B 13.50 2.88 93%
P/E na 30.5 na
Dividend Yield na 0.0% na
PEG (5yr hist) na 1.9 na
Ratios DRTS Industry
Median
Percentile
(All Stocks)
Gross Margin na 59.1% na
Net Margin na (7.7%) na
ROA (40.0%) (13.7%) 14%
ROE (52.8%) (15.9%) 15%
Liabilities to Assets 27.0% 44.9% 18%
F-Score 2 4 7%

Alpha Tau Medical Ltd. did not pass any screens on 7/30/2026.

Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.

Ⓒ 2026 American Association of Individual Investors